Soleus Capital Management, L.P. Q1 2020 Filing
Filed May 15, 2020
Portfolio Value
$85.9B
Holdings
48
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (48 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | EPIEURESSA PHARMA INC | 2,080,421 | $8.3B | 9.68% | |
| 2 | GRFSGRIFOLS S A | 387,035 | $7.8B | 9.07% | |
| 3 | OPHTEURIVERIC BIO INC | 1,607,153 | $5.5B | 6.43% | |
| 4 | —HARPOON THERAPEUTICS INC | 470,926 | $5.5B | 6.35% | |
| 5 | IRMDIRADIMED CORP | 234,810 | $5.0B | 5.83% | |
| 6 | ALXNALEXION PHARMACEUTICALS INC | 47,800 | $4.3B | 4.99% | |
| 7 | ZYXIQZYNEX INC | 348,564 | $3.9B | 4.49% | |
| 8 | DC4DEXCOM INC | 13,450 | $3.6B | 4.21% | |
| 9 | VCELVERICEL CORP | 352,332 | $3.2B | 3.76% | |
| 10 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 313,900 | $3.1B | 3.57% | |
| 11 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 405,207 | $2.8B | 3.21% | |
| 12 | —ALLERGAN PLC | 14,600 | $2.6B | 3.01% | |
| 13 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 536,497 | $2.5B | 2.91% | |
| 14 | —MISONIX INC | 238,333 | $2.2B | 2.61% | |
| 15 | —ZYMEWORKS INC | 61,528 | $2.2B | 2.54% | |
| 16 | —ANTARES PHARMA INC | 864,100 | $2.0B | 2.37% | |
| 17 | ABBVABBVIE INC | 26,500 | $2.0B | 2.35% | |
| 18 | UNHUNITEDHEALTH GROUP INC | 7,900 | $2.0B | 2.29% | |
| 19 | AXNX*AXONICS MODULATION TECHNOLOG | 63,000 | $1.6B | 1.86% | |
| 20 | —ITAMAR MED LTD | 114,865 | $1.4B | 1.57% | |
| 21 | RFLRAFAEL HLDGS INC | 89,131 | $1.1B | 1.33% | |
| 22 | —KADMON HLDGS INC | 257,141 | $1.1B | 1.25% | |
| 23 | —ZAFGEN INC | 1,348,399 | $1.0B | 1.21% | |
| 24 | BIIBBIOGEN INC | 3,000 | $949.0M | 1.10% | |
| 25 | ESTAESTABLISHMENT LABS HLDGS INC | 63,254 | $914.0M | 1.06% | |
| 26 | AXGNAXOGEN INC | 75,050 | $781.0M | 0.91% | |
| 27 | —MILLENDO THERAPEUTICS INC | 147,406 | $778.0M | 0.91% | |
| 28 | PTCTPTC THERAPEUTICS INC | 16,300 | $727.0M | 0.85% | |
| 29 | CRSPCRISPR THERAPEUTICS AG | 16,400 | $696.0M | 0.81% | |
| 30 | AM6AMICUS THERAPEUTICS INC | 72,000 | $665.0M | 0.77% | |
| 31 | —CONSTELLATION PHARMCETICLS I | 17,900 | $563.0M | 0.66% | |
| 32 | ENTAENANTA PHARMACEUTICALS INC | 10,600 | $545.0M | 0.63% | |
| 33 | CTSOCYTOSORBENTS CORP | 69,600 | $538.0M | 0.63% | |
| 34 | LVGOLIVONGO HEALTH INC | 18,100 | $516.0M | 0.60% | |
| 35 | SWAVUSDSHOCKWAVE MED INC | 12,185 | $404.0M | 0.47% | |
| 36 | NVCRNOVOCURE LTD | 5,597 | $377.0M | 0.44% | |
| 37 | RLMDRELMADA THERAPEUTICS INC | 11,000 | $375.0M | 0.44% | |
| 38 | AMRNAMARIN CORP PLC | 90,000 | $360.0M | 0.42% | |
| 39 | STAASTAAR SURGICAL CO | 7,798 | $252.0M | 0.29% | |
| 40 | —TCR2 THERAPEUTICS INC | 30,624 | $237.0M | 0.28% | |
| 41 | PCRXPACIRA BIOSCIENCES | 7,000 | $235.0M | 0.27% | |
| 42 | SNDXSYNDAX PHARMACEUTICALS INC | 20,980 | $230.0M | 0.27% | |
| 43 | —ADURO BIOTECH INC | 81,200 | $222.0M | 0.26% | |
| 44 | —AYTU BIOSCIENCE INC | 139,600 | $209.0M | 0.24% | |
| 45 | VNDAVANDA PHARMACEUTICALS INC | 19,000 | $197.0M | 0.23% | |
| 46 | RVNCEURREVANCE THERAPEUTICS INC | 11,869 | $176.0M | 0.20% | |
| 47 | INSM 1.75 01/15/25INSMED INC | 180,000 | $150.0M | 0.17% | |
| 48 | XENEXENON PHARMACEUTICALS INC | 13,228 | $150.0M | 0.17% |